CONMED Corporation (CNMD)

Gross profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Gross profit (ttm)	US$ in thousands	712,471	698,456	687,520	685,056	678,399	625,932	609,488	590,575	571,245	595,239	585,930	575,577	568,035	547,693	539,085	469,590	460,300	466,761	463,174	522,435
Revenue (ttm)	US$ in thousands	1,305,025	1,286,126	1,274,003	1,260,907	1,244,743	1,168,565	1,139,075	1,098,613	1,045,472	1,068,576	1,042,315	1,020,286	1,010,636	989,493	978,501	881,125	862,458	874,495	870,250	950,728
Gross profit margin		54.59%	54.31%	53.97%	54.33%	54.50%	53.56%	53.51%	53.76%	54.64%	55.70%	56.21%	56.41%	56.21%	55.35%	55.09%	53.29%	53.37%	53.37%	53.22%	54.95%

December 31, 2024 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $712,471K ÷ $1,305,025K
= 54.59%

CONMED Corporation has maintained a relatively stable gross profit margin over the past few years, with fluctuations within a narrow range. The trend shows a gradual increase from around 54.95% in March 2020 to a peak of 56.41% in March 2022. Subsequently, there was a slight decline in the following quarters before stabilizing around 54%-56% range.

The company's ability to maintain a gross profit margin above 50% indicates efficient cost management and effective pricing strategies. The fluctuation in the margin might be influenced by factors such as changes in input costs, pricing decisions, and sales volume.

Overall, the gross profit margin trend for CONMED Corporation demonstrates a consistent focus on profitability and operational efficiency. It is important for the company to continue monitoring and managing factors that impact the gross margin to sustain and improve its financial performance.